Oral GLP-1s Without Fasting or Reduced Efficacy

Originally published May 21, 2026

New oral drug delivery approach protects peptide-based drugs like GLP-1s from destruction in the stomach. Read more at https://pratt.duke.edu/news/oral-glp-1/

Next
Next

Emily Song named 2026 Duke faculty scholar